UNC13C: A Protein with Potential as A Drug Target Or Biomarker

Target Name: UNC13C

NCBI ID: G440279

UNC13C

UNC13C: A Protein with Potential as A Drug Target Or Biomarker

UNC13C (UNC13C variant 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Recent studies have suggested that UNC13C may be a drug target (or biomarker) for a number of diseases, due to its involvement in various cellular processes that are disrupted in these conditions. For example, UNC13C has been shown to be highly expressed in breast cancer tissues, and has been associated with the development of various breast cancer subtypes. Additionally, UNC13C has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Furthermore, UNC13C has also been implicated in autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. In these conditions, the immune system attacks the body's own tissues, leading to inflammation and damage. UNC13C has been shown to be involved in the regulation of immune cell function, and has been thought to play a role in the development of these autoimmune disorders.

Despite these potential implications, more research is needed to fully understand the role of UNC13C in diseases. One approach that researchers are taking is to use techniques such as RNA interference and gene editing to knock down or activate UNC13C in order to study its function. This has led to a better understanding of the molecular mechanisms that govern UNC13C's activity, and has identified potential drug targets or biomarkers for these diseases.

In addition to its potential as a drug target or biomarker, UNC13C is also of interest to researchers because of its role in the regulation of cell growth and differentiation. This is an important process that is fundamental to the development and maintenance of tissues and organs, and is involved in the regulation of many cellular processes, including the cell cycle, cell adhesion, and cell signaling.

Understanding how UNC13C regulates cell growth and differentiation may also have implications for the development of new treatments for diseases. For example, if UNC13C is shown to be involved in the regulation of cell adhesion, researchers may be able to develop new treatments that target this process in order to improve the effectiveness of current treatments.

Overall, UNC13C is a protein that has the potential to be a drug target or biomarker for a number of diseases. Further research is needed to fully understand its role in these conditions, and to identify new treatments that can be developed based on this research.

Protein Name: Unc-13 Homolog C

Functions: May play a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway. May be involved in the regulation of synaptic transmission at parallel fiber - Purkinje cell synapses (By similarity)

The "UNC13C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UNC13C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets